In a phase 3 trial, 67% of children treated with omalizumab tolerated 600 mg of peanut protein, a dramatic increase over just 7% with placebo, highlighting omalizumab’s potential in managing pediatric food allergies.
New research compares human milk antibody levels against infectious pathogens across different income countries, revealing important insights for infant health.
From overflowing cribs to empty pediatric wings, new data reveals a 133.3% difference in children's hospital bed occupancy rates between the most and least crowded states.
The FDA has classified the recall of certain tubes as the most serious type, which could cause severe injury or death. Specific lots of the tubes sold under the Bivona brand for neonatal or pediatric and adult patients are being recalled due to a manufacturing defect.
Reuters
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Patients with type 2 diabetes may face an 83% higher risk of developing asthma, while patients with asthma are 28% more likely to develop diabetes, revealing a bidirectional relationship.
A study in Hormones and Behavior delves into the impact of behavioral problems, environmental noise, maternal stress, and air pollution on hair cortisol levels in 11-year-old children.
A study funded by the Melinda and Bill Gates Foundation demonstrates the potential of intranasal neomycin to elicit broad-spectrum antiviral immunity in the upper respiratory tract, providing significant protection against upper respiratory infections in animal models and showing promising results in a pilot human study.